The frequency of liver fibrosis and clinical symptoms in patients with opisthorchiasis
- Authors: Gorchilova E.G1, Tsukanov V.V.2, Tonkikh Y.L2, Vasyutin A.V2, Rzhavicheva O.S1
-
Affiliations:
- Private Healthcare Institution “Clinical Hospital “Russian Railways-Medicine" of the city of Krasnoyarsk"
- Federal Research Center “Krasnoyarsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences"
- Issue: Vol 27, No 2 (2020)
- Pages: 54-59
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/312512
- DOI: https://doi.org/10.18565/pharmateca.2020.2.54-59
- ID: 312512
Cite item
Abstract
Full Text
About the authors
E. G Gorchilova
Private Healthcare Institution “Clinical Hospital “Russian Railways-Medicine" of the city of Krasnoyarsk"Krasnoyarsk, Russia
Vladislav V. Tsukanov
Federal Research Center “Krasnoyarsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences"
Email: gastro@impn.ru
Dr. Sci. (Med.), Professor, Head of the Clinical Department of Pathology of Digestive System in Adults and Children, Scientific Research Institute of Medical Problems of the North Krasnoyarsk, Russia
Yu. L Tonkikh
Federal Research Center “Krasnoyarsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences"Research Institute of Medical Problems of the North Krasnoyarsk, Russia
A. V Vasyutin
Federal Research Center “Krasnoyarsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences"Research Institute of Medical Problems of the North Krasnoyarsk, Russia
O. S Rzhavicheva
Private Healthcare Institution “Clinical Hospital “Russian Railways-Medicine" of the city of Krasnoyarsk"Krasnoyarsk, Russia
References
- Цуканов В.В., Селиверстова Е.В., Догадин С.А. Показатели липидного состава сыворотки крови и желчи при заболеваниях желчевыводящих путей у больных сахарным диабетом. Терапевтический архив. 2005;77(2):15-8.
- Цуканов В.В., Тонких Ю.Л., Бронникова Е.П., Манчук В.Т Механизм нормолипидемии у северных народностей. Клиническая медицина. 1999;77(2):38-9.
- Sripa B, Jumnainsong A., Tangkawattana S., Haswell M.R. Immune Response to Opisthorchis viverrini Infection and Its Role in Pathology Adv Parasitol. 2018;102:73-95. Doi: 10.1016/ bs.apar.2018.08.003.
- Saltykova I.V, Petrov V.A., Logacheva M.D., et al. Biliary Microbiota, Gallstone Disease and Infection with Opisthorchis felineus. PLoS Negl Trop Dis. 2016;10(7):e0004809. doi: 10.1371/journal. pntd.0004809.
- Edwards S.W., Spofford E.M., Price C. et al. Opisthorchiasis-Induced Cholangiocarcinoma: How Innate Immunity May Cause Cancer. Adv Parasitol. 2018;101:149-76. Doi: 10.1016/ bs.apar.2018.05.006.
- Bouvard V., Baan R., Straif K. et al. A review of human carcinogens - Part B: biological agents. Lancet Oncol. 2009;10(4):321-22. doi: 10.1016/s1470-2045(09)70096-8.
- Максимова Г.А., Жукова Н.А., Кашина Е.В. и др. Роль Opisthorchis felineus в индукции рака желчных протоков. Паразитология. 2015;49(1):3-11.
- Fedorova O.S., Kovshirina Y.V., Kovshirina A.E., et al. Opisthorchis felineus infection and cholangiocarcinoma in the Russian Federation: A review of medical statistics. Parasitol Int. 2017;66(4):365-71. Doi: 10.1016/j. parint.2016.07.010
- Parkin D.M., Bray F., Ferlay J., Pisani P Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2):74-108. doi: 10.3322/canjclin.55.2.74
- Poynard T., Bedossa P., Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997;349(9055):825-32. doi: 10.1016/s0140-6736(96)07642-8.
- McMahon B.J., Bruce M.G., Koch A., et al. The diagnosis and treatment of Helicobacter pylori infection in Arctic regions with a high prevalence of infection: Expert Commentary Epidemiol Infect. 2016;144(2):225-33. Doi: 10.1017/ S0950268815001181.
- Cappellesso R., Fassan M., Hanspeter E., et al. HER2 status in gastroesophageal cancer: a tissue microarray study of 1040 cases. Hum Pathol. 2015;46(5):665-72. Doi: 10.1016/j. humpath.2015.02.007.
- Штыгашева О.В., Цуканов В.В. Ассоциация Cаg A и Vac A штаммов Helicobacter pylori и язвенной болезни в организованной популяции г. Абакана. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2004;14(2):84-7.
- Цуканов В.В., Амельчугова О.С., Каспаров Э.В. и др. Роль эрадикации Helicobacter pylori в профилактике рака желудка. Терапевтический архив. 2014;86(8):124-27.